STOCK TITAN

AXT Inc - AXTI STOCK NEWS

Welcome to our dedicated news page for AXT (Ticker: AXTI), a resource for investors and traders seeking the latest updates and insights on AXT.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AXT's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AXT's position in the market.

Rhea-AI Summary
AXT, Inc. expects to report revenue of $22.4 to $22.7 million for Q1 2024, surpassing previous guidance. The growth is driven by demand for indium phosphide and gallium arsenide substrates in various sectors. The company will release financial results on May 2, 2024, followed by a conference call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.79%
Tags
-
Rhea-AI Summary
AXT, Inc. (NasdaqGS: AXTI) reported Q4 2023 revenue of $20.4 million, with 18% sequential growth. GAAP gross margin was 22.6%, operating loss was ($3.6) million. Fiscal year 2023 revenue was $75.8 million, with a net loss of ($17.9) million. Tongmei's STAR Market IPO approval received.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
69.3%
Tags
-
Rhea-AI Summary
AXT, Inc. (NasdaqGS: AXTI) will release its Q4 2023 financial results on February 22, 2024, followed by a conference call to discuss the results. The call will be accessible online and via phone, with replays available until March 7, 2024. Investor information can be found on the company's website or by contacting the Investor Relations Department.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.41%
Tags
Rhea-AI Summary
AXT, Inc. reports Q3 2023 financial results with revenue of $17.4 million, down from $18.6 million in Q2 2023. GAAP gross margin was 10.7%, compared to 9.2% in Q2 2023. The company focuses on cost savings and efficiency to return to profitability. Tongmei's IPO on the STAR Market is subject to review and approval by CSRC.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.76%
Tags
-
Rhea-AI Summary
AXT, Inc. to announce Q3 2023 financial results
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.43%
Tags
-
Rhea-AI Summary
AXT, Inc. announces subsidiary's receipt of initial export permits to resume shipping gallium arsenide and germanium substrates to certain customers in compliance with new export control regulations in China.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.86%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.73%
Tags
-
Rhea-AI Summary
AXT, Inc. reports Q2 2023 financial results with revenue of $18.6 million, a decrease from previous quarters. GAAP gross margin was 9.2% and operating expenses were $8.6 million. The company also provides an update on the listing of its subsidiary, Tongmei, on the STAR Market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.35%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.7%
Tags
Rhea-AI Summary
AXT, Inc. announces Q2 earnings release on Aug. 3, 2023. The company addresses the potential impact of China's new export control regulations on gallium- and germanium-related materials. Tongmei, AXT's subsidiary in China, will seek permits to export gallium and germanium substrate products. Indium phosphide substrates are not affected. In Q1 2023, gallium arsenide and germanium substrates exported outside of China contributed $4.3 million in revenue. AXT is actively pursuing permits to minimize disruption to customers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
AXT Inc

Nasdaq:AXTI

AXTI Rankings

AXTI Stock Data

134.51M
40.15M
6.69%
51.48%
4.37%
Semiconductor and Related Device Manufacturing
Manufacturing
Link
US
Fremont

About AXTI

axt designs, develops, manufactures and distributes high performance compound and single element semiconductor substrates comprising gallium arsenide, indium phosphide and germanium through its manufacturing facilities in beijing, china. in addition, axt maintains its sales, administration and customer service functions at its headquarters in fremont, ca.